Global orthopedic sales totaled $59 billion in 2023, an increase of 6.5% compared to 2022. Read our regularly updated analysis of the orthopedic market, including sales forecasts for all segments, company revenue and insight into key trends.
Global orthopedic sales totaled $59 billion in 2023, an increase of 6.5% compared to 2022. Read our regularly updated analysis of the orthopedic market, including sales forecasts for all segments, company revenue and insight into key trends.
Stay up to date on the orthopedic market’s 2Q performance in 2024 as we update this post with company sales data and industry developments.
The U.S. remains the world’s largest orthopedic market by revenue, but companies see significant opportunities for international growth.
The company’s orthopedic sales grew in the high single digits in 2024, driven by new products and healthy procedure demand.
The company’s orthopedic business grew in the low-single-digits in 2024 as it faced restructuring and competitive headwinds.
The top four players in spine are fully invested in enabling technology and are changing the competitive dynamics of the segment.
Earnings season for 4Q24 is still a few weeks away, so let’s look ahead to 2025 and our expectations for orthopedics’ top players.
The largest joint replacement companies are averaging double-digit knee replacement sales growth outside the U.S. over the last two years.
The company grew 3.8% in 2024 driven by better operational performance and strategic efforts to enter higher-growth markets.
The company’s orthopedic sales grew below-market at 2% in 2024 as it worked through significant supply chain challenges.
We look ahead and discuss three trends that could impact the landscape of the joint replacement market in 2025 and beyond.
Stay up to date on the orthopedic market’s 4Q performance in 2024 as we update this post with company sales data and industry developments.
The company’s orthopedic sales grew in the high single digits in 2024, driven by new products and healthy procedure demand.
The company’s orthopedic business grew in the low-single-digits in 2024 as it faced restructuring and competitive headwinds.
The top four players in spine are fully invested in enabling technology and are changing the competitive dynamics of the segment.
Earnings season for 4Q24 is still a few weeks away, so let’s look ahead to 2025 and our expectations for orthopedics’ top players.
The largest joint replacement companies are averaging double-digit knee replacement sales growth outside the U.S. over the last two years.
Proceeds will support patient access to metal-free OSSIOfiber surgical implants, which provide a fixation solution while leaving nothing permanent behind.
Login
Register for a free account
As a guest member you get access to more articles and videos every month.